North American Molecular Diagnostics Market Size, Share & Trends Report

North American Molecular Diagnostics Market Size, Share & Trends Analysis Report By Technology, By Application (Oncology, CVD), By Test Location (PoC, OTC), By Product (Instruments, Reagents), And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-073-6
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • North America MDx Product Outlook (Revenue, USD Million, 2014 - 2025)
    • Instruments
    • Reagents
  • North America MDx Test Location Outlook (Revenue, USD Million, 2014 - 2025)
    • Point-of-Care (PoC)
    • Self-test or Over the Counter (OTC)
    • Central Laboratories
  • North America MDx Technology Outlook (Revenue, USD Million, 2014 - 2025)
    • Polymerase chain reaction (PCR)
      • Multiplex PCR
      • Other PCR
    • In Situ Hybridization
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and Microarrays
    • Mass Spectrometry
    • Sequencing
    • Transcription Mediated Amplification
    • Others
  • North America MDx Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Oncology
      • Breast Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Kidney Cancer
      • Liver Cancer
      • Blood Cancer
      • Lung Cancer
      • Other Cancer
    • Pharmacogenomics
    • Infectious Diseases
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Disease
    • Genetic Testing
      • Newborn Screening
      • Predictive and Presymptomatic Testing
      • Other Genetic Testing
    • Neurological Disease
    • Cardiovascular Disease
    • Microbiology
    • Others
  • North America MDx Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • The U.S.
      • U.S Molecular Diagnostics Market, by Product
        • Instruments
        • Reagents
      • U.S. Molecular Diagnostics Market, by Test Location
        • Point-of-Care
        • Self-test or Over the Counter
        • Central Laboratories
      • U.S. Molecular Diagnostics Market, by Technology
        • Polymerase chain reaction (PCR)
          • Multiplex PCR
          • Other PCR
        • In Situ Hybridization
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
        • Chips and Microarrays
        • Mass Spectrometry
        • Sequencing
        • Transcription Mediated Amplification
        • Others
      • U.S. Molecular Diagnostics Market, by Application
        • Oncology
          • Breast Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Kidney Cancer
          • Liver Cancer
          • Blood Cancer
          • Lung Cancer
          • Other Cancer
        • Pharmacogenomics
        • Infectious Diseases
          • Methicillin-resistant Staphylococcus Aureus (MRSA)
          • Clostridium Difficile
          • Vancomycin-resistant Enterococci (VRE)
          • Carbapenem-resistant Bacteria
          • Flu
          • Respiratory Syncytial Virus (RSV)
          • Candida
          • Tuberculosis and drug-resistant TBA
          • Meningitis
          • Gastrointestinal Panel Testing
          • Chlamydia
          • Gonorrhea
          • HIV
          • Hepatitis C
          • Hepatitis B
          • Other Infectious Disease
        • Genetic Testing
          • Newborn Screening
          • Predictive and Presymptomatic Testing
          • Other Genetic Testing
        • Neurological Disease
        • Cardiovascular Disease
        • Microbiology
        • Others
    • Canada
      • Canada Molecular Diagnostics Market, by Product
        • Instruments
        • Reagents
      • Canada Molecular Diagnostics Market, by Test Location
        • Point-of-Care
        • Self-test or Over the Counter
        • Central Laboratories
      • Canada Molecular Diagnostics Market, by Technology
        • Polymerase chain reaction (PCR)
          • Multiplex PCR
          • Other PCR
        • In Situ Hybridization
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
        • Chips and Microarrays
        • Mass Spectrometry
        • Sequencing
        • Transcription Mediated Amplification
        • Others
      • Canada Molecular Diagnostics Market, by Application
        • Oncology
          • Breast Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Kidney Cancer
          • Liver Cancer
          • Blood Cancer
          • Lung Cancer
          • Other Cancer
        • Pharmacogenomics
        • Infectious Diseases
          • Methicillin-resistant Staphylococcus Aureus (MRSA)
          • Clostridium Difficile
          • Vancomycin-resistant Enterococci (VRE)
          • Carbapenem-resistant Bacteria
          • Flu
          • Respiratory Syncytial Virus (RSV)
          • Candida
          • Tuberculosis and drug-resistant TBA
          • Meningitis
          • Gastrointestinal Panel Testing
          • Chlamydia
          • Gonorrhea
          • HIV
          • Hepatitis C
          • Hepatitis B
          • Other Infectious Disease
        • Genetic Testing
          • Newborn Screening
          • Predictive and Presymptomatic Testing
          • Other Genetic Testing
        • Neurological Disease
        • Cardiovascular Disease
        • Microbiology
        • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon